Gabelli Funds’s NEOPHOTONICS CORP NPTN Stock Holding History

Gabelli Funds’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-376,171	Closed	-$5.92M	–	1446
2022 Q2	$5.92M	Buy	376,171 +100,993	+37%	+$1.54M	0.05%	425
2022 Q1	$4.18M	Buy	275,178 +25,048	+10%	+$381K	0.03%	550
2021 Q4	$3.84M	Buy	+250,130	New	+$3.29M	0.02%	579

Other funds holding NPTN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Gabelli Funds's NPTN Position: Q3 2022 in Review

Gabelli Funds sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 376,171 shares — an estimated $5.92M sold.

Gabelli Funds first reported a position in NPTN in Q4 2021 and held it in 3 quarters. The position peaked at $5.92M in Q2 2022. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

Gabelli Funds reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
Gabelli Funds sold 376,171 NEOPHOTONICS CORP shares in Q3 2022, an estimated $5.92M.
Gabelli Funds first reported a position in NEOPHOTONICS CORP in Q4 2021 and held it in 3 quarters.
Gabelli Funds's NEOPHOTONICS CORP position peaked at $5.92M in Q2 2022.
2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Gabelli Funds's 13F filing for Q3 2022, filed 10 Nov 2022.